Global endometrial DNA methylation analysis reveals insights into mQTL regulation and associated endometriosis disease risk and endometrial function

Otros/as autores/as

Institut Català de la Salut

[Mortlock S] The Institute for Molecular Bioscience, The University of Queensland, Brisbane, Australia. [Houshdaran S] Center for Reproductive Sciences, Department of Obstetrics, Gynecology & Reproductive Sciences, University of California San Francisco, San Francisco, CA, USA. [Kosti I] Bakar Computational Health Sciences Institute, University of California San Francisco, San Francisco, CA, USA. [Rahmioglu N] Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK. Oxford Endometriosis CaRe Centre, Nuffield Department of Women’s and Reproductive Health, John Radcliffe Hospital, University of Oxford, Oxford, UK. [Nezhat C] Stanford University Medical Center, Palo Alto, CA, USA. University of California San Francisco, San Francisco, CA, USA. Camran Nezhat Institute, Center for Special Minimally Invasive and Robotic Surgery, Woodside, CA, USA. [Vitonis AF] Obstetrics and Gynecology Epidemiology Center, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA. [Santamaria X] Carlos Simon Foundation, Health Research Institute, Valencia, Spain. Grup de Recerca Biomèdica en Ginecologia, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain

Vall d'Hebron Barcelona Hospital Campus

Fecha de publicación

2023-09-20T08:48:19Z

2023-09-20T08:48:19Z

2023-08-16



Resumen

Epigenomics; Genetic predisposition to disease; Urogenital reproductive disorders


Epigenómica; Predisposición genética a la enfermedad; Trastornos reproductivos urogenitales


Epigenòmica; Predisposició genètica a la malaltia; Trastorns reproductius urogenitals


Endometriosis is a leading cause of pain and infertility affecting millions of women globally. Herein, we characterize variation in DNA methylation (DNAm) and its association with menstrual cycle phase, endometriosis, and genetic variants through analysis of genotype data and methylation in endometrial samples from 984 deeply-phenotyped participants. We estimate that 15.4% of the variation in endometriosis is captured by DNAm and identify significant differences in DNAm profiles associated with stage III/IV endometriosis, endometriosis sub-phenotypes and menstrual cycle phase, including opening of the window for embryo implantation. Menstrual cycle phase was a major source of DNAm variation suggesting cellular and hormonally-driven changes across the cycle can regulate genes and pathways responsible for endometrial physiology and function. DNAm quantitative trait locus (mQTL) analysis identified 118,185 independent cis-mQTLs including 51 associated with risk of endometriosis, highlighting candidate genes contributing to disease risk. Our work provides functional evidence for epigenetic targets contributing to endometriosis risk and pathogenesis. Data generated serve as a valuable resource for understanding tissue-specific effects of methylation on endometrial biology in health and disease.


This work has been supported by the National Institutes of Health (NIH) NICHD R01 HD089511. It was also supported, in part, by funding from Wellbeing of Women (through sponsorship from PwC) (R42533) and the Medical Research Council (MR/N024524/1 and MR/N022556/1) and NIH HD094842 (Harvard/MSU). K.K. was supported by NIH NCI R37 CA233774. A.F.M. was supported by an Australian Research Council Future Fellowship (FT200100837). G.W.M. was supported by NHMRC Fellowship (GNT1177194).

Tipo de documento

Artículo


Versión publicada

Lengua

Inglés

Publicado por

Nature Portfolio

Documentos relacionados

Communications Biology;6

https://doi.org/10.1038/s42003-023-05070-z

Citación recomendada

Esta citación se ha generado automáticamente.

Derechos

Attribution 4.0 International

http://creativecommons.org/licenses/by/4.0/

Este ítem aparece en la(s) siguiente(s) colección(ones)